Industry groups urge members to submit DIR comments to CMS by Jan. 25NACDS and NCPA are urging members to send comments about DIR fees to CMS by Jan. 25. Propeller Health integrates Walgreens into ‘My Pharmacy’ toolThe "My Pharmacy" tool in the Propeller Health mobile app will allow patients to refill prescriptions for pickup at Walgreens locations, talk live with a Walgreens pharmacist and check their Balance Rewards points. Acorda Therapeutics' Inbrija gets approval Acorda Therapeutics' Inbrija helps patients who may experience OFF episodes as Parkinson’s progresses. Amgen's Nplate pediatric indication gets FDA approval Amgen has received the Food and Drug Administration's approval for Nplate for pediatric patients with immune thrombocytopenia. MinuteClinic debuts in Dallas, Pennsylvania MinuteClinic has added a location inside a Dallas, Pa., CVS Pharmacy store. CVS Health's Merlo touts Aetna integration, opening of concept store Six weeks after closing its merger with Aetna, CVS Health president and CEO Larry Merlo outlined new initiatives. Cardinal Health Foundation provides grant for Ohio opioid initiative The Cardinal Health Foundation is providing a $530,000 grant to fight opioid misuse and abuse. Amgen cuts prices for Repatha devices Amgen’s Repatha device options, including its prefilled syringe, are being offered at a 60% reduced price of $5,850 per year. Ritzman sells Rx business to CVS Pharmacy CVS Pharmacy is set to acquire 20 of Ritzman Pharmacy's retail pharmacies by the end of February. FDA approves Lupin's generic Latuda Lupin has received the FDA's approval for generic Latuda tablets, which had a market value of roughly $3.2 billion. First Previous 540 541 542 543 544 Next Last
